News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Meets on Merck & Co., Inc.'s Mevacor; OTC Cholesterol Drug Sought
December 13, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Drug maker Merck will make a third attempt Thursday to convince the government to allow its cholesterol-lowering pill Mevacor to be sold without a prescription.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Tariffs
Trump Carves Tariff Exemptions for Some Pharma Products
September 12, 2025
·
2 min read
·
Tristan Manalac
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
September 11, 2025
·
2 min read
·
Tristan Manalac
CDC
Ousted CDC Director Monarez to Testify In Front of Senate After RFK Jr. Clash
September 10, 2025
·
2 min read
·
Tristan Manalac
